Jubilant Life Sciences

Jubilant Life To Buy Triad Isotopes' Radio-Pharmacy Business, Shares Gain

Business | NDTV Profit Team | Friday May 5, 2017

Jubilant Life Sciences said Triad operates the second largest radio-pharmacy network in the US with more than 50 pharmacies.

Nearly 200 Stocks Hit 52-Week High On BSE

Business | Press Trust of India | Thursday January 5, 2017

Among major gainers were IL&FS Transportation Networks, IOC, Jubilant Life Sciences, MMTC and MOIL, taking the total number of companies to have touched their one year peak to 192.

Jubilant Life Sciences Unit Signs US Deal, Shares Surge Over 10%

Business | Wednesday January 4, 2017

At day's high, Jubilant Life Sciences shares recorded gains of more than 13 per cent in two trading sessions.

Jubilant Life Sciences Announces Price Hike Of Up To 15%

Business | Press Trust of India | Tuesday December 20, 2016

Jubilant Life Sciences is engaged in pharmaceuticals, life science ingredients and drug discovery solutions.

Jubilant Life Seeks Shareholders' Nod To Raise Upto Rs 1,000 Crore

Business | Press Trust of India | Friday November 25, 2016

This approval to the board to raise the amount also stipulates that this could be done in one or more series/tranches during a period of one year from the date of passing the resolution, it added.

Jubilant Life Sciences Posts Nearly 15% Rise In Q2 Profit

Business | Press Trust of India | Thursday October 27, 2016

Jubilant Life Sciences said its international revenues were at Rs 984 crore, contributing 69 per cent to the revenues for the quarter.

Jubilant Life Gets USFDA Nod For Urinary Incontinence Drug

Business | Press Trust of India | Thursday October 13, 2016

Jubilant Life Sciences said it has received 6 approvals from the USFDA during the year.

Jubilant Life Sciences Arm Gets Australia TGA Nod For Lung Scan Drug

Business | Press Trust of India | Wednesday October 5, 2016

Jubilant Life Sciences on Tuesday said its wholly-owned subsidiary has received approval from the Australian health regulator Therapeutic Goods Administration (TGA) for Lyophilized kit for preparation of injection used for lungs scan.

Jubilant Life Shares Jump 10% As Arm Gets USFDA Nod For Drug

Business | Press Trust of India | Monday October 3, 2016

Shares of Jubilant Life Sciences on Monday surged 10 per cent after the company's wholly-owned subsidiary received approval from the US health regulator for a new drug in the US market.

Jubilant Pharma Raises $300 Million Via Bonds

Business | Press Trust of India | Friday September 30, 2016

Drug firm Jubilant Life Sciences today said its subsidiary Jubilant Pharma has raised $300 million (approx Rs 1,998 crore) through issuance of five-year bonds to mainly retire debts.

Jubilant Life Jumps 8% On USFDA Nod For Hypertension Tablets

Business | Press Trust of India | Thursday August 25, 2016

Jubilant Life Sciences stock surged nearly 8 per cent after it received final approval from the US health regulator to sell tablets used in the treatment of hypertension in the American market.

Jubilant Life Gets USFDA Nod For Hypertension Tablets

Business | Press Trust of India | Wednesday August 24, 2016

Jubilant Life Sciences said it has received approval from the US health regulator for Telmisartan Tablets, used for the treatment of hypertension, in the American market.

Jubilant Life Sciences Surges Over 50% In 7 Days. Read Why

Business | NDTV Profit Team | Thursday August 18, 2016

Shares of Jubilant Life Sciences shares surged 15 per cent today to a fresh 52-week high of Rs 506, extending their strong run since the pharma company announced its June quarter earnings last week.

Jubilant Life Sciences Posts 22% Rise In Q1 Profit

Business | Press Trust of India | Wednesday August 10, 2016

Jubilant Life Sciences on Tuesday posted a 22.48 per cent rise in consolidated net profit at Rs 161.60 crore for the first quarter that ended on June 30, on robust sales in the pharmaceuticals segment.

Jubilant Life Sciences Shares Jump On Approval For Epilepsy Injection

Business | NDTV Profit Team | Monday June 6, 2016

With this approval, Jubilant Life Sciences' total Abbreviated New Drug Application (ANDA) approvals rose to 517 in various regions globally, the company said.